By: Marie Huang
–
| M | C | O | N | E | E | E | Y | L | O | N |
| E | L | U | L | M | D | N | F | T | I | E |
| C | S | M | M | A | O | E | L | L | N | N |
| L | O | U | N | F | I | N | U | I | E | N |
| I | N | E | O | E | T | A | T | A | N | O |
| Z | M | A | N | I | L | O | I | E | I | O |
| I | U | T | O | I | C | A | C | L | L | C |
| N | I | S | T | I | E | O | A | N | L | U |
| E | P | B | N | N | O | D | S | T | Y | I |
| Y | O | E | S | T | T | T | O | C | H | T |
| A | R | X | E | I | D | S | N | C | P | R |
| M | T | K | H | B | U | D | E | S | O | N |
| D | O | X | Y | L | A | M | I | N | E | E |
FIND THE FOLLOWING WORDS:
DOXYLAMINE
CODEINE
ALBUTEROL
MONTELUKAST
FLUTICASONE
BUDESONIDE
TIOTROPIUM
MECLIZINE
BENZONATATE
NICOTINE
NOTICE A THEME?
By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…
By: Archana Murugan, PharmD candidate c/o 2029 Overview Thiamine metabolic dysfunction syndrome (TMDS) refers…
By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028 The…
By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…
By: Sariah Grant, PharmD Candidate c/o 2027 The rise of glucagon-like peptide -1 receptor…
By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…